Bliss GVS Pharma Limited (BOM:506197)
India flag India · Delayed Price · Currency is INR
519.50
-4.55 (-0.87%)
At close: Aug 17, 2026

Bliss GVS Pharma Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
10,0529,2718,0977,7027,5167,475
Revenue Growth
20.59%14.50%5.13%2.48%0.55%29.49%
Gross Profit
5,3494,7933,7923,6953,3803,444
Operating Income
1,6441,311977.581,242986.491,013
Net Income
1,3621,291842.99754.54708.59150.4
Earnings Per Share
12.6212.007.957.116.721.43
EPS Growth
25.28%50.94%11.81%5.80%369.93%-77.97%

Revenue by Geography

Fiscal YearFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '25 Mar '24 Mar '23 Mar '22
India
673.41530.18444.42391.62562.32
Outside India
8,4987,4887,2157,0836,817
Total
9,1728,0187,6597,4747,379

Cash & Debt

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
1,8861,8861,4131,404683.591,349
Total Debt
217.5217.5881.04998.41,0191,094
Net Cash (Debt)
1,6691,669532.41405.27-335.39255.5
Net Cash Growth
213.45%213.45%31.37%---
Net Cash Per Share
15.4715.515.023.82-3.182.43

Cash Flow & CapEx

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-1,3871,0591,028343.141,355
Capital Expenditures
--568.31-762.86-283.29-937.99-740.03
Free Cash Flow
-818.87296.27744.87-594.86614.78
Free Cash Flow Growth
-176.39%-60.23%--12.09%

Margins

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
53.21%51.70%46.83%47.98%44.98%46.07%
Operating Margin
16.36%14.14%12.07%16.13%13.13%13.55%
Pretax Margin
20.09%20.45%15.52%15.17%14.11%7.25%
Profit Margin
13.55%13.93%10.41%9.80%9.43%2.01%
FCF Margin
-8.83%3.66%9.67%-7.92%8.22%

Dividends

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Dividend Per Share
2.0001.5000.5000.5000.5000.500
Dividend Per Share Growth
200.00%200.00%0%0%0%0%
Dividend Yield
0.38%0.70%0.43%0.45%0.71%0.67%

Valuation

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
41.1617.6614.6915.6310.4753.05
Forward PE
-6.576.576.576.576.57
P/FCF Ratio
67.4027.8541.8115.83-12.98
PS Ratio
5.492.461.531.530.991.07